BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10817502)

  • 21. Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer.
    Orikasa K; Fukushige S; Hoshi S; Orikasa S; Kondo K; Miyoshi Y; Kubota Y; Horii A
    J Hum Genet; 1998; 43(4):228-30. PubMed ID: 9852672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    Blood; 2000 May; 95(9):2937-42. PubMed ID: 10779442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
    Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
    Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of PTEN mutations in metastatic melanoma specimens.
    Celebi JT; Shendrik I; Silvers DN; Peacocke M
    J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
    Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
    Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).
    Leupin N; Cenni B; Novak U; Hügli B; Graber HU; Tobler A; Fey MF
    Br J Haematol; 2003 Apr; 121(1):97-100. PubMed ID: 12670337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
    Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
    Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
    Li YL; Tian Z; Wu DY; Fu BY; Xin Y
    World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19.
    Chi H; Tiller GE; Dasouki MJ; Romano PR; Wang J; O'keefe RJ; Puzas JE; Rosier RN; Reynolds PR
    Genomics; 1999 Mar; 56(3):324-36. PubMed ID: 10087200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
    Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
    Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
    García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.